I love it when things work out!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well ... This wasn't the news I was expecting, but this seems like a pretty big deal. I assumed we'd hear about some additional acquisition or acquisitions.
I had seen the news about the shareholder meeting. They were going to propose increasing the authorized shares, approve the possibility of a reverse split and a couple other proposals. But I hadn't guessed a major change in direction would be in the cards.
Now the proverbial cat is out of the bag more information should be forthcoming. Since the news flow had started, I'm guessing we'll be hearing more about their future plans right along.
NEWS 1-22-2020 Q2Earth Signs Exclusive Option Agreement to License Promising Drug to Treat Bone Cancer in Children
https://finance.yahoo.com/news/q2earth-signs-exclusive-option-agreement-140010633.html
Palm Beach, FL, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that it has signed an Exclusive Dealing Option Agreement to provide the Company a 90-day period to negotiate with IGL Pharma Inc., and potentially execute a worldwide, exclusive license agreement for the radiopharmaceutical Samarium-153 DOTMP (“Sm-153 DOTMP”). Sm-153 DOTMP is a promising drug with initial indications for pediatric osteosarcoma, a devastating form of bone cancer afflicting children.
The option to license Sm-153 DOTMP was brought to the Company by its newest Director, Douglas Baum, a senior executive with over 28 years of experience in biosciences and drug and medical device commercialization. IGL Pharma is an affiliated entity of ISOTherapeutics Group, LLC, whose founders created Quadramet® (Samarium-153-EDTMP) one of the first effective commercial radiopharmaceuticals.
Sm-153-DOTMP uses low specific activity Samarium-153 and a superior chelator, DOTMP, which eliminates off-target migration and targets high bone turn over making it an ideal agent to treat osteosarcoma, bone metastases and to perform bone marrow ablation. Sm-153 DOTMP has been cleared by the FDA under an investigator IND to commence human dosing of actual patients – children with osteosarcoma.
“This is a very interesting and meaningful opportunity for Q2. And while entry into the human health sector is a departure from soil health, it is our responsibility to pursue viable opportunities that can potentially create significant value for our shareholders. Such a license would be consistent with our 2020 strategic plan to secure new biosciences technologies, and possibly help us raise additional capital and repay currently maturing debt,” stated Kevin Bolin, the Company’s Chairman and CEO.
Mr. Baum, Director of Q2, stated: “If we are successful in securing the license for Samarium-153 DOTMP, I am confident that we can quickly assemble the team needed to commence clinical trials for this very important new drug. Based on my research and experience in this field, I believe Sm-153 DOTMP has a good chance of an expedited path through FDA, and an end market into multiple indications for cancer therapy.”
About Q2Earth: Q2Earth currently manages compost and soil manufacturing facilities, and holds a license for an all-natural soil health supplement called ABS. The Company is pursuing additional licensing opportunities in biotech and biosciences that will expand its intellectual property portfolio and create new business opportunities.
Legal Notice Regarding Forward-Looking Statements: This news release contains "Forward-looking Statements". These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to our ability to fully commercialize our technology, risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new products and markets, the time and expense involved in such development activities, the ability to secure additional financing, the ability to consummate acquisitions and ultimately integrate them, the level of demand and market acceptance of our products, and changes in our business strategies. This is not an offering of securities and securities may not be offered or sold absent registration or an applicable exemption from the registration requirements.
Contact
Christopher Nelson
cnelson@q2earth.com
NEWS 1-16-2020 Q2Earth Appoints Douglas Baum, Senior Biosciences Executive, To Board of Directors
https://finance.yahoo.com/news/q2earth-appoints-douglas-baum-senior-140010911.html
Palm Beach, FL, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that it has appointed Douglas R. Baum to its Board of Directors.
Mr. Baum brings to the Company over 28 years of experience in the bioscience and biotech industries, including development, commercialization and marketing of multiple drugs and medical devices. Over his long senior executive tenure, including as CEO of Xeris Pharmaceuticals, he has overseen 15 product approvals through the FDA and raised over $80 million in capital to fund breakthrough technologies.
“We are pleased and honored to have Doug join our board. We have a great deal of faith that he can help us pursue a strategy that includes expanding our licensing portfolio and business lines into new areas of biotechnology.” stated Kevin Bolin, the Company’s Chairman and CEO.
Mr. Baum stated: “This is an exciting opportunity for me, and I look forward to working with the Q2 team. I feel confident that I can help the Company execute its vision and bring interesting opportunities to the table in the short term while building long-term shareholder value.”
The Board of Directors of Q2 has authorized a strategic plan for 2020 which is comprised of: (1) securing new technologies and business opportunities in the broader biosciences sector, including both human and soil health; and (2) significantly reducing debt and liabilities of the Company and eliminating under-performing assets and agreements. The successful results of these actions are intended to attract new capital to fund long term growth opportunities for the Company.
In connection with his appointment, Mr. Baum initially received 200,000 stock options, vesting over the following two years.
About Q2Earth: Q2Earth currently manages compost and soil manufacturing facilities, and holds a license for an all-natural soil health supplement called ABS. The Company is pursuing additional licensing opportunities in biotech and biosciences that will expand its intellectual property portfolio and create new business opportunities.
Legal Notice Regarding Forward-Looking Statements: This news release contains "Forward-looking Statements". These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to our ability to fully commercialize our technology, risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new products and markets, the time and expense involved in such development activities, the ability to secure additional financing, the ability to consummate acquisitions and ultimately integrate them, the level of demand and market acceptance of our products, and changes in our business strategies. This is not an offering of securities and securities may not be offered or sold absent registration or an applicable exemption from the registration requirements
Contact
Christopher Nelson
cnelson@q2earth.com
Sounds intriguing. I've put you and them on my follow lists. :)
Yep... there was talk early that the funds they were raising were going to be a dilution of 20 or 30 million shares, but then the founder was going to cancel 20 million of his own shares... which he did.
Later I heard there was going to be possibly another 10 or 11 million shares. We're presently at 150 Million shares outstanding. That's basically 70 million shares that have been sold in the 2 to 3 cent range.
https://www.otcmarkets.com/stock/SIRC/security
I think sometimes the money from dilution becomes too easy. The company may do still do great and significantly appreciate in value.
However, at this point, I'm thinking more about an exit strategy than building my position.
Interesting. So essentially they will transform basic heating coal into a more usable and efficient fuel source?
I'm not familiar with that technology. From my cursory study, Ramaco and American Resource Corp are basically mining companies that specialize in metallurgical coal. I know they are both focused on Met Coal A and B, and PCI.
From the financials, it's clear that METC is further along in their marketing and business plan as their average price (selling) per ton was over $110 per ton, while AREC still had a mixture of regular coal and their average was less-- in the $80s to $90s (not certain without looking it up).
All FWIW.
Is CCTI a public company? I couldn't see bid/ask. From your description, maybe the acronym is CCTC?
https://www.cleancoaltechnologiesinc.com/about-us/overview/
I like QPWR's story and am buying some 1 cent shares.
As I look over the historical pricing I don't believe shares have traded at these levels.
Time will tell how this fits together with the company and its future plans.
A stockholders' meeting is scheduled for the first week in February. I'm guessing this is one of the pieces to the puzzle(known to management-- for us as investors to figure out).
Time will tell.
NEWS 1/9/20 Q2Earth Appoints Douglas Baum, Senior Biosciences Executive, To Board of Directors
January 16, 2020 09:00 ET | Source: Q2Earth, Inc
Palm Beach, FL, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that it has appointed Douglas R. Baum to its Board of Directors.
Mr. Baum brings to the Company over 28 years of experience in the bioscience and biotech industries, including development, commercialization and marketing of multiple drugs and medical devices. Over his long senior executive tenure, including as CEO of Xeris Pharmaceuticals, he has overseen 15 product approvals through the FDA and raised over $80 million in capital to fund breakthrough technologies.
“We are pleased and honored to have Doug join our board. We have a great deal of faith that he can help us pursue a strategy that includes expanding our licensing portfolio and business lines into new areas of biotechnology.” stated Kevin Bolin, the Company’s Chairman and CEO.
Mr. Baum stated: “This is an exciting opportunity for me, and I look forward to working with the Q2 team. I feel confident that I can help the Company execute its vision and bring interesting opportunities to the table in the short term while building long-term shareholder value.”
The Board of Directors of Q2 has authorized a strategic plan for 2020 which is comprised of: (1) securing new technologies and business opportunities in the broader biosciences sector, including both human and soil health; and (2) significantly reducing debt and liabilities of the Company and eliminating under-performing assets and agreements. The successful results of these actions are intended to attract new capital to fund long term growth opportunities for the Company.
In connection with his appointment, Mr. Baum initially received 200,000 stock options, vesting over the following two years.
About Q2Earth: Q2Earth currently manages compost and soil manufacturing facilities, and holds a license for an all-natural soil health supplement called ABS. The Company is pursuing additional licensing opportunities in biotech and biosciences that will expand its intellectual property portfolio and create new business opportunities.
Legal Notice Regarding Forward-Looking Statements: This news release contains "Forward-looking Statements". These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to our ability to fully commercialize our technology, risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new products and markets, the time and expense involved in such development activities, the ability to secure additional financing, the ability to consummate acquisitions and ultimately integrate them, the level of demand and market acceptance of our products, and changes in our business strategies. This is not an offering of securities and securities may not be offered or sold absent registration or an applicable exemption from the registration requirements
Contact
Christopher Nelson
cnelson@q2earth.com
https://www.globenewswire.com/news-release/2020/01/16/1971473/0/en/Q2Earth-Appoints-Douglas-Baum-Senior-Biosciences-Executive-To-Board-of-Directors.html
This seems disconcerting...
125,000,000 Shares of Common Stock at $0.025 per Share
Minimum Investment: 40,000 Shares ($1,000.00)
Maximum Offering: $3,125,000.00
just released: http://archive.fast-edgar.com/20200115/AQL2822CZ222O2Z2222822ZYRSS88H226222
Hey. Not sure about CCTC, but both Ramaco and AREC focus on the metallurgical coal part of the market.
AREC seems to have a cash flow problem. But I'm hoping they'll produce even half of their 2020 projections
Intriguing day for SPYR.
1. SEC filling asking to with withdraw S-1 Registration.
My response? I have no idea whether this is a good thing or bad.
2. Stock didn't trade much volume 120k or so, and for a time the bid was at the high for the day.
My response? Mildly encouraged. The stock has pretty well been floundering for the last 1 to 2 years. There have been some expectations and occasionally hope that SPYR was going to turn a corner and actually become a company with growing revenue, but so far it has just been wishful thinking.
3. For the last 1/2 hour of the trading day there was a bid for 400k shares.
Me: Why? Again, another good question. Certainly with a bid like that, it was unlikely that we would close lower than the 3 cents we closed at. Could there be a reason? Will that bidder start buying the asks? Don't know. But intriguing.
4. SPYR has remained up to date with it's quarterly or annual filings.
I've posited in the past that this has been the one part of the equation that has continued to give me hope. Will SPYR actually close on some acquisition(s) and become a profitable company?
It might all be a pipe dream, unless it's not. Who knows, maybe we're finally close to some of these aspirations becoming a reality?
Year-End News: American Resources Corporation Provides Mining Reclamation and Environmental Update:
Company is Reclaiming Irrational Thermal Coal Mines While Continuing Its Growth of Metallurgical Carbon for Steelmaking
FISHERS, INDIANA / ACCESSWIRE / December 31, 2019 / American Resources Corporation (NASDAQ:AREC) ("American Resources" or the "Company"), a supplier of raw materials to the rapidly growing global infrastructure marketplace with a primary focus on the extraction, processing and distribution of metallurgical carbon to the steel and specialty alloy metals industries, is pleased to provide an update on its environmental reclamation of non-core mining properties. The Company's environmental focus is to continuously evaluate its mining permits and identify those properties that are at or below their proprietary (economic and environmental) margin and slate them for reclamation. Throughout the company's strategic acquisition plan, when an acquired mining complex involves both thermal and metallurgical properties, it immediately identifies such thermal coal permits, used for utility power generation, as below the margin.
American Resources, since inception, has strategically acquired and restructured mining complexes to set itself up for being one of the fastest-growing, lowest cost metallurgical carbon platforms in the Central Appalachian basin over the next few years through cost-cutting and right-sizing operations to fit the current and future market conditions. To date, American Resources has acquired over 75 mining permits with an associated reclamation bonding amount in excess of $36 million. To date, the Company has reclaimed, or is currently working to complete reclamation, on 25 thermal mining sites with an associated environmental reclamation liability of over $16.7 million.
Historically, the coal mining industry has deferred many environmental reclamation liabilities out for decades, instead of deeming such permits as "reclamation only" permits, in the hope that certain permits will rise above the margin and become active mines again in the future and/or to avoid permanent reclamation of such properties. American Resources, instead, has chosen not to defer that liability and deems such sites as "reclamation only" with a goal of remediating, and in certain cases, repurposing irrational mining sites that fall below the margin. Reclamation only permits are those that a company has decided to completely reclaim and not attempt to defer the reclamation work for a later time. This approach has resulted, at times, in the Company setting very aggressive reclamation deadlines for it to achieve. Consequently, as with many mining companies, this has caused American Resources to, at times, be named on the Office of Surface Mining Reclamation and Enforcement's (OSMRE) Applicant Violators System (AVS) list for trying to adhere to such aggressive final reclamation deadlines. As the Company expeditiously completes and progresses on this reclamation, it will naturally be removed from the AVS list, as the case with all other mining companies. Regardless, the Company and its team are proud of its desire to reduce the environmental footprint of its below-the-margin and thermal mines and remains focused exclusively on its specially metals and metallurgical carbon operations.
"Because our acquisition plan included complexes that often consisted of permits tied to both metallurgical carbon (used for steel making) and thermal coal (used for electricity generation), our strategic restructuring and environmental focus has been to separate the two assets by quality types.", stated Mark Jensen, Chief Executive Officer of American Resources Corporation. "Immediately post-acquisition, we then look to reclaim thermal coal mining sites that do not fit within our business model, while tying the metallurgical carbon assets into our existing operating growth platform. Our focus is to grow and expand our metallurgical carbon platform, but at the same time find efficient and viable solutions to either reclaim or repurpose the land associated with the thermal coal assets we acquire. Our goal here is to work with our partners to find the right solutions to benefit the environment and local communities, and in some cases create viable commercial uses for the land, while also reducing our overall environmental liability costs."
American Resources Corporation will continue to identify operational efficiencies and ways to reduce future liabilities in its continuing goal to be one of the lowest cost operators and responsible stewards of the environment in Central Appalachia and throughout all its coal mining, processing, and transportation operations.
About American Resources Corporation
American Resources Corporation is a supplier of raw materials to the rapidly growing global infrastructure marketplace. The company's primary focus is on the extraction, processing, transportation and selling of metallurgical carbon and pulverized coal injection (PCI) to the steel industry. The company operations are based in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical products are located.
The company's business model is based on running a streamlined and efficient operation to economically extract and deliver resources to meet its customers' demands. By running operations with low or no legacy costs, American Resources Corporation works to maximize margins for its investors while being able to scale its operations to meet the growth of the global infrastructure market.
Website:
http://www.americanresourcescorp.com
Special Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the Company's actual results, performance, or achievements or industry results to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond American Resources Corporation's control. The words "believes", "may", "will", "should", "would", "could", "continue", "seeks", "anticipates", "plans", "expects", "intends", "estimates", or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Any forward-looking statements included in this press release are made only as of the date of this release. The Company does not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent events or circumstances. The Company cannot assure you that the projected results or events will be achieved.
Institutional/Retail/Individual Contact:
PCG Advisory
Adam Holdsworth
646-862-4607
adamh@pcgadvisory.com
www.pcgadvisory.com
Company Contact:
Mark LaVerghetta
317-855-9926 ext. 0
Vice President of Corporate Finance and Communications
investor@americanresourcescorp.com
https://www.otcmarkets.com/stock/AREC/news/story?e&id=1503716
Some things are hard to predict. I'm guessing the next financials out will be the 10K... which won't be out till March. But I'm guessing they will give some indications of whether their earlier projections are on target or off.
The quick trip to 80 plus cents the other day was intriguing. Not sure who wins long term by the price being held down. I'm thinking that change will be fairly dramatic.
We shall see.
FWIW, I've been adding to my position.
Agreed. There are certainly some question if that can be overcome.
At this point things have been pretty dark. Hopefully, we'll learn more in the new year.
I was surprised by the way this started trading yesterday.
Not sure if anything has changed, but from I've read there should still be just over 300K in the public float, and the debt burden was supposed to have been converted to reality at a $1 it so pretty share.
I've been waiting to hear what's coming next. Why restructure and reorganize the share structure of the company?
Hopefully, it will be to monetize and carry out it's business plan.
Wishful thinking? Perhaps. We shall see what 2020 brings.
Historically, the most reliable information I've found is on the company's website l
https://www.gcfb.com/company-info/
However, it corresponds to the information on www.otcmarkets.com ( which I hadn't seen BTW).
The company's stock has certainly been trading like bad news is coming. I thought maybe it was year-end selling, but now I'm not so sure.
Agreed. I'm hoping the trade agreements being worked on will call grown and prosperity astounded the world. In that scenario, infrastructure green around the globe is s given.
Part and parcel of infrastructure growth will be the need for high quality steel which needs metallurgical coking coal.
When and if all that happens, we should be in for a pretty serious ride.
Encouraging promotional article about AREC's future.
https://finance.yahoo.com/news/american-resources-corporation-drilling-success-130800592.html
I appreciate your encouragement and enthusiasm.
By Volume I would agree... but being on a listed international exchange enables buyers from certain countries to purchase shares.
And (speculating) I would think it would also simplify uplisting to the full TSX and eventually the NASDAQ Capital exchange.
Fortem Resources is continuing to plod along.
They've been able to get their filings amended and current. The outcome of the whole process has cost the company time and money.
However, the company has come through the process with a greatly increased net asset value and stronger.
It's my understanding that the company is working to get reinstated on the Toronto Venture Exchange. However, as we saw with our initial listing there, the wheels turn fairly slow.
I believe the company is continuing to work for their and our eventual success.
I guess you have to post every now and then so that you continue being a moderator.
Who know with SPYR? It still seems like a bit of a crapshoot. But the company has been maintaining its QB rating... and is a fully reporting company, maintaining audits.
If nothing else, this keeps the door open to acquiring other companies or I suppose being acquired by another company... so there's always the possibility of future life.
PLUS... as I type... there's a trailing bid of 178K shares.
Pretty sure this means that there are more people that just me expecting 2020 to be an exciting for AREC.
So far today, we've made two runs over 80 cents.
Looks like those expecting the share price to go lower were wrong.
Are you kidding me...
AREC trades 10 or 20 times its normal volume and not one posts or notices!!!
From recent PR.
"We expect to be able to announce another milestone to our plan next week after the holiday."
Not sure how close you watch the bids and asks, but SPYR had a 500K share bidder at 2.1 cents today before the close.
It will be interesting to see if it's there tomorrow, and whether it's a serious buyer that will eventually take out some offers.
Agreed. I think AREC is experiencing some year-end loss selling, but if they can start putting up numbers any where close to those projected, I think 2020 will be a huge breakout year for them.
At this point I hardly dare to hope... but yes I too rellish the possibility.
Came looking for the same.
Sometimes I wonder... but there is a certain validity to that train of thought.
In the end, the plan almost has to be something. If not something, why bother?
At this point... I'm holding a pretty decent position. If we go anywhere positive, and especially if go somewhere with a profitable acquisition, there will be some serious profits to be made.
We shall see!
Randy
Intriguing.
So at least theoretically, with this reduction of 55 Billion Stellar Lumens tokens, the potential value of our tokens has increased by 50%.
Or not?
Not been paying attention, but the volume. Zonks.
Once selling is finished, it will trade higher. I have no idea how much higher.
A lot of shares have been caught at current levels ... How the company's story will be told and to whom... And to what effect... will decide the outcome. If we see steady and increasing volume and price, I would suggest holding your position.
This could turn into a beautiful thing... if and when it doubles take out your cost and then then wait and see. When it seems like the good times are never going to end... It's probably time to sell the rest and move on.
All just my opinion, I've been wrong plenty of times in the past.
Yep. I guess there's a reason the stock price had been hanging out at sub 4 cent levels.
As I said before companies can become addicted to the easy money of convertible debt.
I'm quite invested at higher than current levels. The question I have is when will they have enough?
I've don't doubt some of the money raised will be used for promotion (and hopefully a higher stock price), but I guess that's the balancing act we have to put up with.
As I've been tracking the Outstanding Shares, I noticed something today...
Well check the Outstanding Shares today:
They are reporting to 124,862,305 Outstanding.
https://www.otcmarkets.com/stock/SIRC/security
For the last several weeks the outstanding shares have stayed at 133 Million share range.
My assumption is that additional "funding shares issued" have been issued and that as promised our CEO has retired the 20 Million shares he said he would in the September 10, 2019 press release.
https://www.otcmarkets.com/stock/SIRC/news/Solar-Integrated-Roofing-Corporation-CEOAnnounces-Retirement-of-20-Million-Shares?id=239744
So... here's my theory. The company has issued another 5 to 10 million shares as convertible debt... hence the big volume little price move today.
Can anyone confirm that this is the case? Or maybe I'm missing something.
To this point Fortem Resources has been a developmental stage company. It has been gathering oil and gas properties in hopes of securing financing and developing then.
Has all this taken longer than expected? Certainly. Are there valid reasons for why things have not happened as quickly as we had we had hoped? It's a judgement call, but I would say so.
The point we're at is not ideal, but it's also not that that bad. I think the current financial reports are stronger than ever. Our multiple acquisitions are now reported at a value more reflective and reasonable in terms of their potential.
Making guesses at specific prices and time is a crap shoot.
A lot depends on whether or not the company continues financing itself with convertible debt.
I've read they have plans of becoming a legitimate company and perhaps even uplisting to NASDAQ. I'm in favor of that, but easy money is addictive. So we shall see.
I think there's going to be some price fluctuation and appreciation ... But how high and how long is the proverbial question. We shall see.